FDA Approves Noven Pharmaceuticals’ Transdermal Patch for Schizophrenia

FDA Approves Noven Pharmaceuticals’ Transdermal Patch for Schizophrenia

Source: 
BioSpace
snippet: 

The patch is a once-per-day treatment that provides sustained concentrations of Secuado (asenapine), an atypical antipsychotic drug used to treat schizophrenia.